Revance Therapeutics, Inc.
RVNCCIK 0001479290 · Every Form 4 filed by insiders at this issuer.
Filings
15
Latest Mar 19, 2024
Unique insiders
4
Showing
15 of 15
Page 1
Top insiders
Most active reporters at Revance Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Foley Mark J | OfficerDirector | 5 |
| Schilke Tobin | Officer | 4 |
| Moxie Dwight | Officer | 3 |
| Sjuts Dustin S | Officer | 3 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 19, 2024 | Foley Mark J CEO · Director | F | 17,228 | $5.305 | $91,395 | |
| Mar 19, 2024 | Schilke Tobin CFO | S | 9,361 | $5.0426 | $47,204 | |
| Mar 19, 2024 | Moxie Dwight CLO & GC | S | 8,125 | $5.0426 | $40,971 | |
| Mar 19, 2024 | Sjuts Dustin S President | S | 9,211 | $5.0425 | $46,446 | |
| Mar 8, 2024 | Foley Mark J CEO · Director | P | 30,000 | $6.98 | $209,400 | |
| Mar 4, 2024 | Foley Mark J CEO · Director | A | 70,750 | $0.00 | $0 | |
| Mar 4, 2024 | Schilke Tobin CFO | A | 17,447 | $0.00 | $0 | |
| Mar 4, 2024 | Moxie Dwight CLO & GC | A | 15,143 | $0.00 | $0 | |
| Mar 4, 2024 | Sjuts Dustin S President | A | 22,110 | $0.00 | $0 | |
| Feb 2, 2024 | Foley Mark J CEO · Director | Holdings only | — | — | — | |
| Feb 2, 2024 | Schilke Tobin CFO | A | 96,667 | $0.00 | $0 | |
| Feb 2, 2024 | Moxie Dwight SVP, GC & Secretary | A | 90,000 | $0.00 | $0 | |
| Jan 3, 2024 | Foley Mark J CEO · Director | A | 264 | $7.47 | $1,972 | |
| Jan 3, 2024 | Schilke Tobin CFO | A | 434 | $7.47 | $3,242 | |
| Jan 3, 2024 | Sjuts Dustin S President | A | 264 | $7.47 | $1,972 |
Showing 1–15 of 15
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.